<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to enteral nutrition in the premature infant
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to enteral nutrition in the premature infant
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to enteral nutrition in the premature infant
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Amy B Hair, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven A Abrams, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 08, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Premature infants have greater nutritional needs in the neonatal period than at any other time of their lives. The nutrient needs are inherently high at this stage of development to match the high rates of nutrient deposition achieved by infants in utero [
         <a href="#rid1">
          1
         </a>
         ]. In addition, they often have medical conditions that increase their metabolic energy requirements, including hypotension, hypoxia, acidosis, infection, and surgery. Additional impediments to growth are physiologic immaturity of the gastrointestinal tract, including decreased gastrointestinal motility and reduced intestinal enzyme activity, and therapies such as corticosteroids.
        </p>
        <p>
         Early and adequate nutritional support is needed to achieve appropriate rates of weight gain, which are almost twice that of a term infant, and to avoid postnatal growth failure [
         <a href="#rid2">
          2,3
         </a>
         ]. Despite intensive nutritional strategies for premature infants, growth failure remains a major problem [
         <a href="#rid4">
          4
         </a>
         ]. However, intensive feeding strategies must be balanced with potential risks. As an example, while early initiation of enteral feedings has been shown to benefit premature infants, very rapid advancements of enteral feedings may result in feeding intolerance or necrotizing enterocolitis (NEC). In addition, it is important to choose feeding practices associated with improved outcomes for premature infants, such as the use of human milk rather than formula [
         <a href="#rid5">
          5,6
         </a>
         ]. In some cases, when it is not possible to provide full enteral feedings due to an infant's medical condition, it may be necessary to provide partial or total parenteral nutrition. (See
         <a class="medical medical_review" href="/z/d/html/5026.html" rel="external">
          "Parenteral nutrition in premature infants"
         </a>
         .)
        </p>
        <p>
         Issues related to enteral nutrition in the premature infant are reviewed here. The composition of the feeding, including human milk, formula, and human milk fortifiers (HMFs), is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/5047.html" rel="external">
          "Nutritional composition of human milk and preterm formula for the premature infant"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          NUTRITIONAL GOALS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The nutritional goal for premature infants is to achieve rates of growth and nutrient accretion that match those achieved by infants of similar gestational age in utero, while avoiding complications that can be caused by nutritional therapies.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Intrauterine growth and nutrient accretion
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several different growth standards are available for tracking growth of premature infants. These standards are designed to reflect intrauterine growth rates, which are generally not attained during extrauterine growth of premature infants. The relative merits of these growth charts for monitoring growth in premature infants are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5003.html" rel="external">
          "Growth management in preterm infants", section on 'Normative growth data'
         </a>
         .)
        </p>
        <p>
         Rates of intrauterine nutrient accretion during the third trimester have been estimated from chemical analysis of fetal cadavers [
         <a href="#rid7">
          7,8
         </a>
         ]. Data for several minerals have been corroborated by contemporary noninvasive neutron activation techniques [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2006312331">
         <span class="h2">
          Energy requirements
         </span>
         <span class="headingEndMark">
          —
         </span>
         The energy (caloric) requirements to achieve optimal growth are calculated from the estimated resting energy expenditure (REE) plus the energy requirements for activity (including feeding), thermoregulation, fecal loss, growth, and chronic medical conditions  (
         <a class="graphic graphic_table graphicRef59766" href="/z/d/graphic/59766.html" rel="external">
          table 1
         </a>
         ). In term infants between 8 to 63 days of postnatal age, REE varies from 49 to 60 kcal/kg/day [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
         For premature infants, the clinical condition and activities dictate the daily energy requirements, as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For enterally fed premature infants, the average daily energy requirements are 110 to 130 kcal/kg/day [
         <a href="#rid11">
          11,12
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For parenterally fed premature infants, the energy requirements are lower (90 to 100 kcal/kg/day for infants &lt;1500 g) because of less fecal energy loss, fewer episodes of cold stress, and somewhat less activity [
         <a href="#rid12">
          12
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For infants with chronic illness, such as bronchopulmonary dysplasia, energy requirements may be higher due to increased REE, activity, and, possibly, fecal losses [
         <a href="#rid13">
          13,14
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Nutrient requirements
         </span>
         <span class="headingEndMark">
          —
         </span>
         Suggested enteral intakes for other nutrients are listed in the table  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 2
         </a>
         ); the requirements for parenterally given nutrients may differ. The appropriate enteral intake for a particular nutrient can be estimated from established rates of intrauterine accretion, plus estimation of daily losses, divided by the bioavailability (net absorption) of the nutrient [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
         As an example, this approach can be used to estimate calcium (Ca) requirements as follows:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intrauterine accretion rate (bone deposition) – 105 mg/kg/day
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary losses – 5 mg/kg/day
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cutaneous losses – 2 mg/kg/day
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Subtotal net Ca requirement – 112 mg/kg/day
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Net absorption of dietary Ca – 50 percent
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Total Ca intake to meet requirement – 224 mg/kg/day
        </p>
        <p>
        </p>
        <p>
         Clinical conditions will affect absorption of nutrients. For example, absorption of Ca and phosphorus is affected by postnatal age and intake of lactose, fat, and vitamin D. (See
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants", section on 'Enteral nutrition'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h1">
          NUTRITIONAL ASSESSMENT AND MONITORING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nutritional assessment of the premature infant requires determination of the daily energy and nutrient requirements for optimal growth. This assessment requires a knowledge of nutritional biochemistry and neonatal medical conditions.
        </p>
        <p>
         The infant's progress is then monitored by the rate of growth and daily assessments of fluid, energy, and nutrient intake. The nutrient targets are then readjusted if the target growth rate is not met. The dietitian is a key resource to ensure an intake that meets nutrition goals and is compatible with the infant's medical condition.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Rate of growth
         </span>
         <span class="headingEndMark">
          —
         </span>
         Growth is monitored by serial measurements of weight, length, and head circumference and compared with growth standards [
         <a href="#rid16">
          16-19
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weight is assessed daily, targeting a minimum increment of 15 to 20 g/kg/day from 23 to 36 weeks gestation [
         <a href="#rid16">
          16,20
         </a>
         ]. Traditionally, once the infant reaches 2 kg body weight, the goal can be a weight gain of 20 to 30 g/day.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Length is assessed weekly, preferably using a length board, targeting an average increment of 1 cm per week.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Head circumference is assessed weekly, targeting an average increment of 1 cm per week.
        </p>
        <p>
        </p>
        <p>
         Growth parameters are charted on sex-specific growth curves for premature infants. We attempt to keep infants growing at rates above the 10
         <sup>
          th
         </sup>
         percentile on these charts whenever possible, but steady growth along lower percentiles is also acceptable. The charts are helpful for monitoring growth, and computation of the weekly rate of growth is also important. Available growth standards for premature infants are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5003.html" rel="external">
          "Growth management in preterm infants", section on 'Normative growth data'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Laboratory monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         The nutritional status of the very low birth weight (VLBW) infant (birth weight ≤1500 g) is monitored by serial evaluations of biochemical indices.
        </p>
        <p>
         At our institution, we perform these measurements, as indicated in the table  (
         <a class="graphic graphic_table graphicRef53587" href="/z/d/graphic/53587.html" rel="external">
          table 3
         </a>
         ), until the values are in the target range and stable. Other neonatal intensive care units (NICUs) may monitor more (or less) frequently. These assessments include the following:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemoglobin is monitored to assess for anemia, which may affect rate of growth. However, in the NICU, anemia generally is not caused by nutritional deficiencies. (See
         <a class="medical medical_review" href="/z/d/html/4962.html" rel="external">
          "Anemia of prematurity (AOP)"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bone mineral status is assessed by routine laboratory monitoring of serum phosphorus and alkaline phosphatase activity; a protocol for monitoring is summarized in the algorithm  (
         <a class="graphic graphic_algorithm graphicRef131352" href="/z/d/graphic/131352.html" rel="external">
          algorithm 1
         </a>
         ) and discussed in more detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants", section on 'Laboratory monitoring'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Protein status is assessed by monitoring levels of blood urea nitrogen (BUN). BUN &gt;10 mg/dL suggests protein sufficiency [
         <a href="#rid21">
          21
         </a>
         ]. It remains uncertain whether high BUN values (eg, BUN &gt;50 mg/dL, with normal renal function) are a clinically useful marker for excessive protein intake. Serum albumin reflects long-term protein intake (half-life of 21 days), so it is usually not helpful as a marker of protein status in the NICU.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Electrolytes (serum sodium, chloride, and bicarbonate) are typically measured at least once after the transition from parenteral nutrition to full fortified feeds and more often in infants who receive diuretics, who are fed unfortified human milk, whose intakes are limited, or who have slow growth. Infants with abnormal results may require more frequent monitoring and potentially supplementation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Zinc and copper may be measured in infants with unusual intestinal losses, such as those with enterostomies or short bowel syndrome. These measurements are not needed in premature infants without these conditions. (See
         <a class="medical medical_review" href="/z/d/html/5886.html" rel="external">
          "Chronic complications of short bowel syndrome in children", section on 'Nutritional complications'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         The trend in biochemical indices may be more reflective of nutritional status than isolated values. Infants who are receiving parenteral nutrition require more frequent monitoring, especially of electrolytes and glucose. (See
         <a class="medical medical_review" href="/z/d/html/5026.html" rel="external">
          "Parenteral nutrition in premature infants", section on 'Monitoring'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h1">
          INFANTS REQUIRING TUBE FEEDING
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants weighing ≤1800 g birth weight (usually ≤32 weeks gestation) typically require tube feeding until they are sufficiently mature to feed directly from the breast or artificial nipple. The approach depends upon the infant's maturity and clinical condition. Our general approach is outlined below, followed by sections providing the rationale.
        </p>
        <p>
         Oral feeding should be initiated when the infant demonstrates signs of readiness, which typically occurs when the tube-fed infant is between 32 and 34 weeks gestational age. (See
         <a class="local">
          'Infants who can feed orally'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H3955490686">
         <span class="h2">
          Overview of initiation and advancement of feeds
         </span>
         <span class="headingEndMark">
          —
         </span>
         All neonatal intensive care units (NICUs) should adopt a protocol to ensure prompt initiation and advancement of feeds; the details of timing, composition, and rate of advancement vary. Our NICU's protocol for stable infants requiring tube feedings (typically ≤1800 g birth weight) is outlined below  (
         <a class="graphic graphic_table graphicRef118744" href="/z/d/graphic/118744.html" rel="external">
          table 4
         </a>
         ). Infants with significant feeding intolerance or other medical problems may progress more slowly.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Colostrum
         </strong>
         – We give colostrum to infants within the first six hours of life, once a mother is able to express colostrum. We provide 0.2 mL of expressed colostrum every three hours to the buccal mucosa using a small syringe (0.1 mL to each side of buccal mucosa). We use a syringe for milk delivery, based on a study that showed that this dose and delivery method are associated with increased absorption of selective immunoglobulin A (sIgA) and lactoferrin [
         <a href="#rid22">
          22
         </a>
         ]. Other NICUs use a swab to the oropharyngeal mucosa with expressed colostrum every three hours. We continue to administer mother's milk via syringe to the buccal mucosa until the infant is taking full oral feeds. Oropharyngeal colostrum provides immune benefits to the infant as well as an early initiation of maternal milk expression, which favors overall milk production [
         <a href="#rid23">
          23-25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Parenteral nutrition
         </strong>
         – For infants ≤1500 g birth weight, "starter" parenteral nutrition (glucose, amino acids, calcium [Ca], and lipids) is given when feasible to supply part of the energy and nutrient needs. Other high-risk infants such as those with congenital bowel anomalies, congenital heart disease, or congenital diaphragmatic hernia may also require early parenteral nutrition. (See
         <a class="medical medical_review" href="/z/d/html/5026.html" rel="external">
          "Parenteral nutrition in premature infants", section on 'Parenteral nutritional requirements'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Trophic feeds
         </strong>
         – For all infants, small-volume ("trophic") feeds are started within the first day of life and ideally within six hours of life if medically stable.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For most infants, the feeds are given via oropharyngeal or nasogastric tube at 20 mL/kg/day, divided into boluses given every three hours. For very immature infants (22 to 24 weeks gestational age), most NICUs use a more cautious approach. (See
         <a class="local">
          'Trophic feeds'
         </a>
         below and
         <a class="local">
          'Intermittent versus continuous'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Feeding is begun with unfortified mother's own milk. If mother's own milk is not available, pasteurized donor human milk is recommended for infants ≤1500 g birth weight [
         <a href="#rid5">
          5
         </a>
         ]. For infants &gt;1500 g birth weight, formula designed for a premature infant may be used if mother's own milk is unavailable [
         <a href="#rid12">
          12,26
         </a>
         ]. (See
         <a class="local">
          'Milk strength and content'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Trophic feeds may be given to infants who have an umbilical artery catheter (UAC) and an umbilical venous catheter in place or are undergoing medical treatment for patent ductus arteriosus (PDA). (See
         <a class="local">
          'Adjustment for concurrent medical conditions'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Advancement of feeds
         </strong>
         – Feeding volume is advanced gradually. As feeds are advanced, a human milk fortifier (HMF) is added to boost the nutrient intake. In our NICU, the timing of advancement and fortification depends upon the infant's birth weight; our protocol is outlined in the tables  (
         <a class="graphic graphic_table graphicRef118747 graphicRef118748" href="/z/d/graphic/118747.html" rel="external">
          table 5A-B
         </a>
         ). The rate of advancement also depends on feeding tolerance, which is assessed by serial monitoring of clinical signs and symptoms. (See
         <a class="local">
          'Rate of volume increase'
         </a>
         below and
         <a class="local">
          'Fortification of feeds'
         </a>
         below and
         <a class="local">
          'Feeding intolerance'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         As enteral feeds are advanced, the parenteral nutrition solution is gradually decreased. The parenteral nutrition is discontinued when the enteral feeds reach 100 mL/kg/day.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Target volume
         </strong>
         – The target volume for feeds is 160 mL/kg/day of fortified human milk. (See
         <a class="local">
          'Target volume'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Milk strength and content
         </span>
         <span class="headingEndMark">
          —
         </span>
         Whenever possible, human milk should be used rather than formula [
         <a href="#rid5">
          5,6
         </a>
         ]. Full-strength (undiluted) milk should be used throughout the feeding protocol.
        </p>
        <p>
         When mother's milk is not available, pasteurized human donor milk should be used for very low birth weight (VLBW) infants (≤1500 g) [
         <a href="#rid5">
          5,6,27,28
         </a>
         ]. In this case, common practice is to continue donor human milk feeds until the infant reaches approximately 34 weeks postmenstrual age, weighs 2000 g, and/or is ready for hospital discharge [
         <a href="#rid29">
          29
         </a>
         ]. A preponderance of evidence suggests that human milk is associated with lower rates of necrotizing enterocolitis (NEC) and feeding intolerance in VLBW infants compared with preterm formula [
         <a href="#rid26">
          26,30
         </a>
         ]. Some Muslim families may be reluctant to use pooled human donor milk due to Islamic belief about milk kinship, although the interpretation varies among different Muslim communities. This issue calls for culturally sensitive conversations to help the family make a fully informed decision and explore alternatives to pooled donor milk, if needed [
         <a href="#rid31">
          31
         </a>
         ]. (See
         <a class="local">
          'Fortification of feeds'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants", section on 'Use of donor milk'
         </a>
         .)
        </p>
        <p>
         A diet of human milk achieves full enteral feeds more rapidly than a diet of formula. In a study of 127 premature infants (birth weight ≤1250 g), infants fed at least 50 percent human milk achieved full enteral feeds more rapidly than those fed formula alone [
         <a href="#rid32">
          32
         </a>
         ]. In addition, feeding full-strength formula triggers earlier and more consistent intestinal motility responses to feeding compared with diluted formula [
         <a href="#rid33">
          33
         </a>
         ] or water [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Trophic feeds
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest early initiation of low-volume enteral feeds, known as "trophic" feeds or "gastrointestinal priming." For infants who are very premature or ill, the low-volume feeds usually are continued for several days before advancing the milk volume [
         <a href="#rid35">
          35
         </a>
         ]. Some clinicians may be comfortable with a more rapid advancement of feeds, such as giving trophic feeds for only one to three days, and adding HMF to human milk feeds early in the course of feeding advancement (see
         <a class="local">
          'Fortification of feeds'
         </a>
         below). Limited evidence supports this approach [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         The safety of early trophic feeds was supported by a meta-analysis, which concluded that early initiation of trophic feeds was not associated with an increased risk of NEC or all-cause mortality in VLBW infants and may reduce the risk of invasive infection [
         <a href="#rid37">
          37
         </a>
         ]. A separate meta-analysis found that early initiation of feeds (&lt;72 hours of life) was associated with reduced mortality (relative risk 0.69, 95% CI 0.48-0.99) and shorter hospital stay (mean difference -3.2 days, 95% CI -5.74 to -0.66) [
         <a href="#rid38">
          38
         </a>
         ]. Other benefits suggested by earlier trials include better feeding tolerance, more rapid maturation of intestinal motility patterns, and improved markers of bone health [
         <a href="#rid35">
          35,39-44
         </a>
         ].
        </p>
        <p>
         The rationale for early introduction of feeds is that lack of enteral nutrients impairs intestinal development, manifested by diminished intestinal size and weight, atrophy of mucosa, and delayed maturation of intestinal enzymes and motility; some of these effects may be mediated by diminished production of gastrin, which is a trophic hormone for intestinal growth. In addition, lack of enteral nutrients increases intestinal permeability and bacterial translocation, suggesting that it might predispose to sepsis or other infectious complications [
         <a href="#rid39">
          39,45-47
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3820436937">
         <span class="h2">
          Rate of volume increase
         </span>
         <span class="headingEndMark">
          —
         </span>
         Feeding protocols are important tools to support progressive advancement of feeds, combined with close monitoring of an infant's feeding tolerance, which in turn varies with the infant's age and state of health. The details of such protocols vary among centers. Accumulating evidence suggests that feeds can be advanced more rapidly than previously thought for infants who are healthy and show no signs of feeding intolerance, when used in the context of a carefully managed protocol.
        </p>
        <p>
         We suggest the following approach  (
         <a class="graphic graphic_table graphicRef118744" href="/z/d/graphic/118744.html" rel="external">
          table 4
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For healthy infants weighing &lt;1000 g, advance feeds by 20 to 30 mL/kg/day  (
         <a class="graphic graphic_table graphicRef118747" href="/z/d/graphic/118747.html" rel="external">
          table 5A
         </a>
         ). Some institutions may choose to advance feeds on the lower end of this range in infants receiving formula or early fortification (eg, fortifier added when feeding volume reaches 60 mL/kg/day). Other institutions may choose to advance at the higher end of this range (ie, advancing by 30 mL/kg/day) in order to reach full feeds more quickly and reduce the risks associated with an intravenous catheter and parenteral nutrition.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For healthy infants weighing 1000 to 1500 g, and especially those fed exclusively or partially with breast milk, advance feeds by increments of 30 mL/kg/day  (
         <a class="graphic graphic_table graphicRef118748" href="/z/d/graphic/118748.html" rel="external">
          table 5B
         </a>
         ).
        </p>
        <p>
        </p>
        <p>
         Substantial clinical evidence supports this approach of early initiation and relatively rapid advancement of feeds in the context of a carefully managed protocol [
         <a href="#rid48">
          48-55
         </a>
         ]. As an example, one meta-analysis concluded that, for VLBW infants, more rapid advancement of feeds (30 to 40 mL/kg/day compared with 15 to 24 mL/kg/day) does not increase the risk for NEC [
         <a href="#rid54">
          54
         </a>
         ] and another found benefits on time to regain birth weight and shorter hospital stay [
         <a href="#rid55">
          55
         </a>
         ]. A separate randomized trial in 2793 preterm infants (48 percent birth weight 1000 to 1500 g and 37 percent birth weight &lt;1000 g) found that advancing feeds in increments of 30 mL/kg/day compared with 18 mL/kg/day did not affect risks of NEC, late-onset sepsis, or survival without moderate to severe neurodevelopmental disability [
         <a href="#rid53">
          53
         </a>
         ]. Most of the infants in this trial were fed exclusively or partially with breast milk, and fortifier was added after full feeds were reached. These findings support more rapid advancement of feeds than has been traditionally been used, especially for infants &lt;1000 g. Past practices of slower feeding advancement were based on limited data and studies in which infants received more formula feeds compared with the more modern practice of the use of breast milk [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         The timing for advancing from trophic to progressive feeds was evaluated in a meta-analysis, which concluded that earlier advancement of enteral feedings (before the fourth day of life) compared with later advancement of feedings (after four to seven days of life) leads to earlier achievement of full feeds without increasing the risk of NEC [
         <a href="#rid37">
          37
         </a>
         ]. A subsequent randomized trial that focused on infants ≤28 weeks gestation evaluated outcomes of even earlier advancement of feeds, in which all infants began trophic feeds on the first day of life and feedings were advanced by 20 to 24 mL/kg/day starting on the second (early feeding) or fifth (later feeding) day of life [
         <a href="#rid52">
          52
         </a>
         ]. Safety outcomes were similar among those managed with early versus later progressive feeding. (See
         <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">
          "Neonatal necrotizing enterocolitis: Prevention", section on 'Standardized feeding protocol'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3276738472">
         <span class="h2">
          Feeding schedule
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most protocols provide enteral feeds every three hours. Feedings for infants &lt;1500 g are typically given as a gradual bolus on a pump over 30 to 60 minutes. However, one study suggests that a more frequent feeding schedule improves feeding tolerance and reduces the time to attain full feedings. This was illustrated in a study of VLBW infants that compared every-two-hour with three-hour feedings [
         <a href="#rid57">
          57
         </a>
         ]. Infants receiving feedings every two hours had a shorter time to reach full enteral feedings, greater weight gain, fewer days when feedings were held, and fewer days of receiving total parenteral nutrition. The magnitude of the effect was greater in infants who were less than 28 weeks gestation.
        </p>
        <p class="headingAnchor" id="H1859232561">
         <span class="h2">
          Fortification of feeds
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initial feeds are with unfortified human milk (mother's own milk or pasteurized donor milk). As feeds are advanced, an HMF is added to boost the nutrient intake:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In many NICUs, a bovine-derived HMF is used. In this case, we suggest using unfortified breast milk until feeding volume reaches approximately 100 mL/kg/day, then begin fortifying feeds with the HMF, providing 24 kcal/oz. However, this reflects a traditional approach and there are no data to suggest that it is safer than earlier introduction of bovine-derived HMF. As an example, some NICUs may choose to introduce bovine HMF when feeding volume reaches 60 mL/kg/day or even earlier as a method to increase nutrient intake while weaning total parenteral nutrition. Limited evidence suggests that this is safe [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In other NICUs, an HMF derived from donor human milk may be available (eg, Prolact+6). In our NICU, we use this type of HMF for infants ≤1250 g birth weight because of evidence that it leads to fewer complications and improved growth compared with a diet of bovine-derived HMF [
         <a href="#rid58">
          58-60
         </a>
         ]. When using this type of HMF, we start fortification when enteral feeds reach 60 mL/kg/day because early introduction of this type of HMF was found to be safe in controlled trials. Some NICUs may choose to introduce human milk-derived HMF even earlier (eg, when feeding volume reaches 20 to 40 mL/kg/day). This approach was supported by a randomized trial in 150 extremely preterm infants (median birth weight 795 g) that compared early fortification with a human milk-based HMF (added to human milk starting on the second day of feeding) to a diet using standard fortification (fortification with a bovine HMF added to human milk after full enteral nutrition is established, approximately postnatal day 14) [
         <a href="#rid61">
          61
         </a>
         ]. At 36 weeks postmenstrual age, the group treated with early fortification had greater length gain velocity and lesser decline in head circumference for age, with nonsignificant differences in other anthropometric outcomes. The trial did not detect differences in safety outcomes including necrotizing enterocolitis but was underpowered for these outcomes. These results extend previous unmasked studies that suggested that early introduction of fortified feeds is well tolerated when using an all-human milk diet [
         <a href="#rid36">
          36,62-64
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The thresholds for fortification and advancement of feeds vary among NICUs. The protocol that we use in our NICU is shown in the tables  (
         <a class="graphic graphic_table graphicRef118747 graphicRef118748" href="/z/d/graphic/118747.html" rel="external">
          table 5A-B
         </a>
         ). Studies of different types of fortifiers are summarized in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants", section on 'Indications and fortifier types'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4130329969">
         <span class="h2">
          Target volume
         </span>
         <span class="headingEndMark">
          —
         </span>
         The target volume for feeds is approximately 160 mL/kg/day of fortified human milk. Commercially available HMFs add approximately 4 to 6 kcal/oz to provide approximately 130 to 150 kcal/kg/day  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 6
         </a>
         ). This target volume generally supports a weight gain of 15 to 20 g/kg/day. In some NICUs, feeding volumes are advanced up to 180 to 200 mL/kg/day. There is some evidence that target volumes of 180 to 200 mL/kg/day in healthy preterm infants &gt;1000 g birth weight yielded greater increases in weight, length, and head circumference without adverse effects, although this is based primarily on one single-center trial with a wide range of birth weights (1001 to 2500 g) [
         <a href="#rid65">
          65,66
         </a>
         ]. If volumes of enteral feedings are increased to 180 to 200 mL/kg/day, review the total intake of vitamins and minerals from the fortified milk or formula. HMFs and preterm formulas are generally designed to provide an appropriate dose of nutrients at a target volume of 160 mL/kg/day  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h2">
          Feeding intolerance
         </span>
         <span class="headingEndMark">
          —
         </span>
         Difficulty tolerating enteral feedings is a major problem for premature infants, especially in those with gestational age below 28 weeks, those who require positive pressure support, or those who have positive blood cultures [
         <a href="#rid67">
          67
         </a>
         ]. Factors that affect feeding tolerance include intestinal motility, gastric emptying, stool output, digestive enzymes, type of feeds (formula or human milk), rapidity of feeding, volume of feeding, concentration of milk, concomitant medications, and medical conditions. An infant's intolerance of enteral feeding is a primary factor for clinical decision-making to initiate, advance, and discontinue feedings. Thus, feeding intolerance may be a major determinant of the duration of hospitalization.
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Clinical assessment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Serial assessment of feeding tolerance is important to the management of enteral feeding protocols, but there are no universally agreed upon criteria on which to base this judgment.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Symptoms and signs suggesting feeding intolerance
         </strong>
         – Symptoms of feeding intolerance are nonspecific and vary between patients. Most clinicians use a composite of the following clinical symptoms to determine feeding intolerance [
         <a href="#rid68">
          68
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Emesis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdominal examination – Distention or tenderness, bowel sounds increased or absent
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Gastric residual fluid – Change in quantity of fluid (usually increased volume) or change in color to green (bilious) or red (blood)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Stool output – Any change in the frequency of stool output and presence of blood in stools
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Other – Increased episodes of apnea and bradycardia, diminished oxygen saturation (desaturation events), and lethargy
        </p>
        <p>
        </p>
        <p>
         Any of these symptoms should prompt the clinician to reassess the infant and evaluate the possibility of feeding intolerance and/or underlying pathology.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Gastric residual fluid
         </strong>
         – The gastric residual volume (GRV) is the amount of milk left in the stomach several hours after a feeding and is typically measured just prior to a scheduled feeding [
         <a href="#rid69">
          69
         </a>
         ]. It is an indirect measure of gastric emptying and intestinal function and/or pathology but is nonspecific because it may be affected by the position of the infant or the position of the feeding tube. Although some NICUs routinely measure GRVs in asymptomatic infants, there is no evidence that this practice is a useful guide for feeding advancement or that it helps to avoid or detect the onset of NEC [
         <a href="#rid70">
          70-74
         </a>
         ]. Indeed, in a randomized trial in 143 infants &lt;1250 g birth weight who were fed human milk, omission of GRV measurements increased delivery of enteral nutrition, improved weight gain, and led to earlier hospital discharge without significant effects on risk for NEC or other complications [
         <a href="#rid73">
          73
         </a>
         ]. As a result, many NICUs have abandoned the routine measurement of GRV entirely. However, measurement of GRV may still be useful as part of the assessment of an individual infant with symptoms of feeding intolerance, especially abdominal distension or vomiting.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Bloody or bilious gastric fluid
         </strong>
         – The appearance of the gastric residual fluid sometimes provides information about feeding tolerance. Gastric fluid that is green (bilious) usually indicates overdistention of the stomach and retrograde reflux of bile into the stomach but occasionally indicates intestinal obstruction [
         <a href="#rid69">
          69
         </a>
         ]. Blood-tinged gastric fluid is uncommon; when present, it is usually due to a slight mucosal irritation from the indwelling gastric tube but also might indicate an inflammatory process.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stool output
         </strong>
         – Stool output provides an index of intestinal motility. Some clinicians use a small
         <a class="drug drug_pediatric" data-topicid="13337" href="/z/d/drug information/13337.html" rel="external">
          glycerin
         </a>
         suppository to stimulate stool output. More rapid evacuation of meconium during the first week of life is associated with improved feeding tolerance in extremely low birth weight infants [
         <a href="#rid75">
          75
         </a>
         ]. Most clinicians perform imaging before considering giving a suppository to rule out intestinal obstruction.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Blood in stools
         </strong>
         – The presence of gross blood in stools is usually interpreted as a sign of feeding intolerance and should also raise concern for NEC, especially if combined with other symptoms such as abdominal distension, temperature instability, or increased apneas (see
         <a class="medical medical_review" href="/z/d/html/5019.html" rel="external">
          "Neonatal necrotizing enterocolitis: Clinical features and diagnosis"
         </a>
         ). Measurement of occult blood is not supported by the data and is not recommended. Occult blood in the stool is common in infants in an NICU, and its clinical implications are unclear. As an example, in a study of 95 infants with birth weights ≤1800 g, 58 percent had at least one occult blood-positive stool during the first six weeks of life [
         <a href="#rid76">
          76
         </a>
         ]. Six of the infants developed NEC, two of whom had occult blood in their stool and four of whom had no blood in their stool.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Several conditions other than NEC also may cause gross blood in stool and should be considered when evaluating an infant with this finding:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Swallowed blood from delivery, suctioning, intubation, gastric tubes, and breast milk from mothers with nipple trauma.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Anal excoriation or fissures.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Colitis due to infection (such as cytomegalovirus) or milk protein sensitivity. (See
         <a class="medical medical_review" href="/z/d/html/5897.html" rel="external">
          "Food protein-induced allergic proctocolitis of infancy"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Coagulopathy or thrombocytopenia.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormality of the gastrointestinal tract. These are rare and include Meckel's diverticulum, duplication of the small intestine, hemangiomas, lymphangiomas, gastric and duodenal ulcers, intestinal stricture, volvulus, and intussusception. (See
         <a class="medical medical_review" href="/z/d/html/5904.html" rel="external">
          "Lower gastrointestinal bleeding in children: Causes and diagnostic approach", section on 'Neonatal period'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Management
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adjustment of feedings
         </strong>
         – When one or more of the above signs raise significant concerns for feeding intolerance, the clinician may choose to withhold feedings. In this case, the infant should be carefully reassessed and examined prior to the next feeding to aid the decision of whether to resume feedings and/or to make changes in the regimen. Minor or isolated symptoms of feeding intolerance often can be corrected by reducing the volume of feeds or postponing advances in feeding volume. Diluting feeds is not a useful strategy. Multiple or severe symptoms usually require a full evaluation for an underlying problem such as NEC and stopping feeds temporarily. It is important to avoid withholding feeds for prolonged periods of time because lack of enteral feeding hastens the complications of parenteral nutrition and intestinal atrophy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pharmacotherapy
         </strong>
         – Pharmacotherapy is
         <strong>
          not
         </strong>
         recommended as a strategy to manage feeding intolerance in premature infants, because there is little evidence that any agent is effective for this purpose and each is associated with risks.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Acid suppressants
         </strong>
         – Acid-suppressing medications such as histamine type 2 receptor antagonists should not be used to treat feeding intolerance. Although these agents were historically used to treat preterm infants with feeding intolerance, they appear to be associated with higher rates of NEC [
         <a href="#rid77">
          77
         </a>
         ]. Similar considerations may apply to acid suppression with proton pump inhibitors [
         <a href="#rid78">
          78
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4991.html" rel="external">
          "Neonatal necrotizing enterocolitis: Pathology and pathogenesis", section on 'Agents that reduce gastric acidity'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Erythromycin
         </strong>
         – Evidence does not support the use of
         <a class="drug drug_pediatric" data-topicid="13276" href="/z/d/drug information/13276.html" rel="external">
          erythromycin
         </a>
         for the treatment of feeding intolerance in preterm infants. Although erythromycin has prokinetic properties, the results of clinical trials in this population are inconsistent and it is unclear if it is effective [
         <a href="#rid79">
          79,80
         </a>
         ]. As an example, two meta-analyses of randomized studies found only low-quality evidence for efficacy, except perhaps for higher treatment doses [
         <a href="#rid81">
          81,82
         </a>
         ]. Moreover, there are reports of an association between early use of this drug (in the first month) and the development of infantile hypertrophic pyloric stenosis [
         <a href="#rid83">
          83
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5890.html" rel="external">
          "Infantile hypertrophic pyloric stenosis", section on 'Macrolide antibiotics'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Techniques for tube feeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Tube feeding is an essential tool in enteral nutrition because premature infants less than 32 weeks gestation at birth typically are unable to suck and/or coordinate sucking and swallowing with breathing. Tube feeding varies by method (intermittent bolus versus continuous feeds) and by route (orogastric, nasogastric, transpyloric, or gastrostomy).
        </p>
        <p>
        </p>
        <p>
         The device used for tube feeding also depends on the duration of the proposed therapy. For infants who are tube-fed only because of their prematurity, a temporary orogastric or nasogastric tube is used because they will eventually be able to orally feed. Infants with major congenital anomalies may require a semi-permanent gastrostomy.
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Intermittent versus continuous
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most premature infants can and should be fed with intermittent ("bolus") feeds. For infants &lt;1500 g, intermittent feeds are typically administered using an infusion pump over 30 to 60 minutes; larger infants may tolerate more rapid infusions or gravity feeds. The intermittent feeding method mimics the typical feeding routine of term infants and children and stimulates greater hormonal responses than continuous infusions [
         <a href="#rid84">
          84
         </a>
         ]. Intermittent feeds may also reduce the loss of human milk fat in the feeding tube. In one study, fat loss was greater (up to 40 percent) with continuous feedings [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
         For infants without underlying gastrointestinal disease, there is no clear advantage of either feeding technique on clinical outcomes. In a meta-analysis of nine trials involving more than 900 premature infants with birth weights ≤1500 g, intermittent feeds were possibly associated with a slightly earlier time to reaching full enteral feeds compared with continuous feeds [
         <a href="#rid86">
          86
         </a>
         ]. However, the difference was not statistically significant, the quality of the evidence was low, and there was no detectable effect on growth parameters or risk of NEC. Additionally, most data were based on infants &gt;1000 g birth weight, whereas benefits to continuous feeds may be more likely in infants &lt;1000 g birth weight.
        </p>
        <p>
         Continuous feeding may be useful for selected infants with underlying gastrointestinal disease because it can improve feeding tolerance and/or enhance nutrient absorption [
         <a href="#rid87">
          87
         </a>
         ]. Continuous feeds are usually used for infants who are fed via the transpyloric route (to avoid "dumping syndrome," which is seen in older individuals when formula enters rapidly into the jejunum) and for those who have had intestinal surgery. An alternative option is to use intermittent feeds but increase the duration of each feed (ie, slow bolus feeds). In a small group of infants who appeared intolerant to intermittent feedings, duodenal motility and gastric emptying appeared to improve following the lengthening of each feed from 30 minutes to up to 2 hours [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h3">
          Gastric versus transpyloric
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most premature infants can and should be given gastric rather than transpyloric feeds. Transpyloric feeding is used in some institutions for selected infants with persistent gastric residuals or emesis in the absence of obvious intestinal pathology, but selection of infants for transpyloric feeds varies among institutions and clinicians.
        </p>
        <p>
         The potential benefits and risks of transpyloric feeds were evaluated in a systematic review of nine trials [
         <a href="#rid89">
          89
         </a>
         ]. There was no difference in the rate of short-term growth (ie, weight, length, head circumference, and skinfold thickness) between transpyloric versus intragastric feeds. Although there was an increased risk of gastrointestinal disturbance and mortality associated with the transpyloric approach, this may have been due to selection bias, with allocation of the less mature and sicker infants to transpyloric feeds. There was no difference in the incidence of adverse events including NEC, intestinal perforation, and aspiration pneumonia. The authors concluded that there was no benefit to the routine use of transpyloric feeding in preterm infants, while acknowledging methodologic weaknesses in all of the included trials.
        </p>
        <p class="headingAnchor" id="H2118020803">
         <span class="h2">
          Adjustment for concurrent medical conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Enteral feeds usually can be implemented and advanced regardless of other medical interventions, as long as the infant is stable. Specific considerations are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infants with a UAC
         </strong>
         – Enteral feeds can be initiated and advanced in infants who have a UAC in place, as long as the UAC is functioning properly [
         <a href="#rid90">
          90
         </a>
         ]. In the past, concerns were raised about proceeding with enteral feeding in infants who have an indwelling UAC. However, studies of trophic feeds included many infants with a UAC in place and no untoward events were reported [
         <a href="#rid35">
          35,41
         </a>
         ]. Furthermore, a randomized trial found no increased risk of enteral feeding with a UAC in place [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infants receiving treatment for PDA
         </strong>
         – In our NICU, we generally provide trophic feeds during medical treatment for PDA if the infant was already receiving feeds prior to starting treatment, although we do not advance feeds until the PDA treatment is completed. This strategy is supported by a study in infants &lt;1250 g birth weight that showed that premature infants who received trophic feedings during
         <a class="drug drug_pediatric" data-topicid="13371" href="/z/d/drug information/13371.html" rel="external">
          ibuprofen
         </a>
         or
         <a class="drug drug_pediatric" data-topicid="13380" href="/z/d/drug information/13380.html" rel="external">
          indomethacin
         </a>
         treatment for a PDA did not have an increased risk of adverse events, including NEC. Infants who received trophic feeds achieved their target for enteral feedings sooner compared with those who did not [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infants receiving red blood cell transfusions
         </strong>
         – In many NICUs, feeds are held for several hours during and after a red blood cell transfusion, although there is no strong evidence to guide this practice. Several studies (primarily retrospective) have suggested an association between red blood cell transfusions and NEC (transfusion-associated NEC) [
         <a href="#rid93">
          93,94
         </a>
         ]. However, it is possible that the risk of NEC might be related to the degree of anemia rather than the red blood cell transfusion [
         <a href="#rid95">
          95
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5040.html" rel="external">
          "Neonatal necrotizing enterocolitis: Prevention", section on 'Prevent severe anemia/Decrease exposure to RBC transfusion'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1929921264">
         <span class="h1">
          INFANTS WHO CAN FEED ORALLY
         </span>
        </p>
        <p class="headingAnchor" id="H612569623">
         <span class="h2">
          Readiness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oral feeding should be initiated as soon as the infant demonstrates signs of readiness, which typically occurs when the tube-fed infant is between 32 and 34 weeks gestational age. Initiating oral feeds including breastfeeding is discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5035.html" rel="external">
          "Breastfeeding the preterm infant"
         </a>
         .)
        </p>
        <p>
         Although there is some variability, many preterm infants born at &gt;34 weeks gestation can be completely fed orally from birth; others require only a brief period of tube feeding.
        </p>
        <p class="headingAnchor" id="H4272938492">
         <span class="h2">
          Diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants with very low birth weights (VLBWs) generally benefit from an enriched diet before and after discharge, especially if there is slow growth or evidence of protein insufficiency or osteopenia on laboratory monitoring [
         <a href="#rid96">
          96,97
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2644842545">
         <span class="h3">
          Enriched diet
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Indications
         </strong>
         – Some neonatal intensive care units (NICUs) routinely use an enriched diet for VLBW infants, with careful monitoring to avoid excessive growth. In our institution, we provide this diet to any infant with any of the following characteristics:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Birth weight ≤2000 g
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unable to consume at least 180 mL/kg/day due to fluid restriction or poor feeding
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abnormalities in routine laboratory tests suggesting suboptimal bone health, such as low serum phosphorus or elevated alkaline phosphatase activity with a persistently abnormal trend, or low blood urea nitrogen (BUN) suggesting inadequate protein intake (see
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants", section on 'Laboratory monitoring'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Implementation
         </strong>
         – Several approaches can be used to enrich the diet; the choice depends upon the available products and whether the infant is feeding directly from the breast or from an artificial nipple:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For infants who are feeding at the breast, provide two or three feedings daily with a transitional "post-discharge" formula (22 kcal/oz) or premature infant formula (30 kcal/oz). These feeds generally substitute for the breast milk feed for a total of at least eight feeds daily (ie, two formula feeds with at least six feeds at the breast or three formula feeds with at least five feeds at the breast).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For infants who are fed breast milk from an artificial nipple, add bovine milk-based fortifier to breast milk (to provide 22 or 24 kcal/oz) or mix the premature infant formula with breast milk.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For infants fed only formula, we use a transitional "post-discharge" formula (22 kcal/oz).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For any of above strategies, sterilized liquid (rather than powdered) types of infant formula or human milk fortifier are preferred until the infant is at least 44 weeks postmenstrual age due to the small risk of bacterial contamination of powdered products. The risk is probably minimal when using single-serving packets of powdered human milk fortifier. If formula is only available as a powder in multi-serving cans (eg, in low-resource settings), use with careful attention to clean technique and proper storage. (See
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants", section on 'Indications and fortifier types'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A comparison of the nutrients provided by these different discharge feeding strategies is shown in the table  (
         <a class="graphic graphic_table graphicRef118736" href="/z/d/graphic/118736.html" rel="external">
          table 7
         </a>
         ). We change to the discharge diet three to four days prior to the discharge date to ensure tolerance and observe growth. Management of feeds after discharge is discussed in more detail in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/5003.html" rel="external">
          "Growth management in preterm infants", section on 'Routine nutrient supplementation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1542331289">
         <span class="h3">
          Standard diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         For infants who do not meet the above criteria for an enriched diet, we provide feedings of unfortified human milk or term infant formula at 20 kcal/oz, with target volumes of 180 mL/kg/day, and monitor growth closely.
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h1">
          DISCHARGE PLANNING
         </span>
        </p>
        <p class="headingAnchor" id="H2034379528">
         <span class="h2">
          Discharge criteria
         </span>
         <span class="headingEndMark">
          —
         </span>
         We begin planning for nutrition after discharge when the premature infant has attained approximately 50 percent of the target for full oral enteral feeds. We consider discharge from the neonatal intensive care unit (NICU) when the premature infant is maintaining body temperature in a crib and meets
         <strong>
          both
         </strong>
         of the following nutritional milestones:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Feeding by mouth with good documented intake of one of these diets:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Standard diet (20 kcal/oz) at &gt;180 mL/kg/day
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Enriched diet (usually 22 kcal/oz, but it is also reasonable to use 30 kcal/oz, to provide maximum nutrition with the smallest amount of non-breast milk diet) at &gt;160 mL/kg/day
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Breastfeeding with complementary formula feeds of 22 to 30 kcal/oz
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Exclusive breastfeeding
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Established growth rate on the above feeds:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infants ≤2 kg – Gaining at least 15 to 20 g/kg/day
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infants &gt;2 kg – Gaining 20 to 30 g/day (not g/kg/day)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2763632711">
         <span class="h2">
          Follow up
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ongoing monitoring of growth after discharge is important to verify whether optimal growth will continue on ad libitum breastfeeding or standard term formula. When an enriched diet is used, we suggest continuing it for at least six months post-discharge, as long as the infant does not gain too rapidly and cross growth percentiles upward. It is important to communicate the plan for an enriched diet to the clinician who will manage the infant's care after discharge. (See
         <a class="medical medical_review" href="/z/d/html/5003.html" rel="external">
          "Growth management in preterm infants", section on 'After discharge'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2521029322">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/143917.html" rel="external">
          "Society guideline links: Nutrition support (parenteral and enteral nutrition) for neonates including preterm infants"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111345.html" rel="external">
          "Society guideline links: Breastfeeding and infant nutrition"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Goals
         </strong>
         – The goals of nutritional management for premature infants are to mimic intrauterine rates of growth and nutrient accretion. The initial assessment calculates a target for energy (calories) and other nutrients needed to achieve optimal growth, and targets are then adjusted based on the infant's progress. (See
         <a class="local">
          'Nutritional assessment and monitoring'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Introducing and advancing feeds
         </strong>
         – Tube feeding is typically needed for infants weighing ≤1800 g at birth (usually ≤32 weeks gestation). In our neonatal intensive care unit (NICU), we use the following protocol for introducing and advancing feeds, which varies depending on the size and maturity of the infant  (
         <a class="graphic graphic_table graphicRef118744" href="/z/d/graphic/118744.html" rel="external">
          table 4
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Colostrum
         </strong>
         – Expressed colostrum or breast milk is applied to the oropharyngeal mucosa using a syringe or swab, starting after birth and continuing until the infant is taking some feeds orally.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Parenteral nutrition
         </strong>
         – Parenteral nutrition solutions (glucose, amino acids, calcium [Ca], vitamins, and lipids) are started as early as feasible and gradually decreased as enteral feeds increase. (See
         <a class="medical medical_review" href="/z/d/html/5026.html" rel="external">
          "Parenteral nutrition in premature infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Initiate trophic feeds
         </strong>
         – Trophic feeds are given at 20 mL/kg/day, ideally starting within six hours after birth (when medically feasible), using mother's own milk or pasteurized donor human milk. Trophic feeds are generally continued for one to three days before advancing feed volume. (See
         <a class="local">
          'Milk strength and content'
         </a>
         above and
         <a class="local">
          'Trophic feeds'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Feeding advancement
         </strong>
         – For healthy infants, the volume of feedings is commonly advanced by 20 to 30 mL/kg/day in infants &lt;1000 g birth weight, 30 mL/kg/day in those 1000 to 1500 g, and 30 to 40 mL/kg/day in infants &gt;1500 g. The feeding volumes and rate of advancement depend upon the size, maturity, and feeding tolerance of the infant; our protocol is outlined in the tables  (
         <a class="graphic graphic_table graphicRef118747 graphicRef118748" href="/z/d/graphic/118747.html" rel="external">
          table 5A-B
         </a>
         ). (See
         <a class="local">
          'Rate of volume increase'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In general, for infants ≤1500 g birth weight, mother's own milk or pasteurized donor milk is fortified with a human milk fortifier (HMF) partway through the course of feeding advancement. (See
         <a class="local">
          'Fortification of feeds'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Target volume
         </strong>
         – Target volume for feeds is 160 mL/kg/day of fortified human milk, which provides between 24 and 28 kcal/oz, depending on the HMF that is used  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 6
         </a>
         ). The target volume generally is one that supports a weight gain of more than 15 to 20 g/kg/day. When donor human milk is used, we generally switch to premature formula around 34 weeks postmenstrual age. (See
         <a class="local">
          'Target volume'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p>
         (See
         <a class="local">
          'Overview of initiation and advancement of feeds'
         </a>
         above.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Assessment of feeding tolerance
         </strong>
         – Although there are no universally agreed upon criteria to judge feeding intolerance in premature infants, we use the following clinical criteria (see
         <a class="local">
          'Feeding intolerance'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Emesis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of bile or blood
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Changes in stool output and presence of blood
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Abdominal distention, tenderness, and bowel sounds
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased episodes of apnea and bradycardia, diminished oxygen saturation, or lethargy
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Most clinicians use a composite of the above criteria as opposed to a single factor. When present, these parameters should prompt the clinician to evaluate the infant for causes of feeding intolerance and to decide whether to hold feeds temporarily. (See
         <a class="local">
          'Feeding intolerance'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Initiating oral feeds
         </strong>
         – Oral feeding should be initiated as soon as the infant demonstrates signs of readiness, which typically occurs when the tube-fed infant is between 32 and 34 weeks gestational age. Most preterm infants born at &gt;34 weeks gestation do not require a prolonged period of tube feeding and many can be completely fed orally from birth. Discharge feeding strategies depend on birth weight, infant growth, and whether the infant is breastfeeding or solely formula-fed  (
         <a class="graphic graphic_table graphicRef118736" href="/z/d/graphic/118736.html" rel="external">
          table 7
         </a>
         ). (See
         <a class="local">
          'Infants who can feed orally'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1591353955">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Richard J Schanler, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Hay WW Jr, Lucas A, Heird WC, et al. Workshop summary: nutrition of the extremely low birth weight infant. Pediatrics 1999; 104:1360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schanler RJ, Garza C, Nichols BL. Fortified mothers' milk for very low birth weight infants: results of growth and nutrient balance studies. J Pediatr 1985; 107:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butte NF, Garza C, Smith EO, Nichols BL. Human milk intake and growth in exclusively breast-fed infants. J Pediatr 1984; 104:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dusick AM, Poindexter BB, Ehrenkranz RA, Lemons JA. Growth failure in the preterm infant: can we catch up? Semin Perinatol 2003; 27:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker MG, Stellwagen LM, Noble L, et al. Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant. Pediatrics 2021; 148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meek JY, Noble L, Section on  Breastfeeding. Policy Statement: Breastfeeding and the Use of Human Milk. Pediatrics 2022; 150.
          </a>
         </li>
         <li class="breakAll">
          Widdowson EM. Importance of nutrition in development, with special reference to feeding low-birth-weight infants. In: Meeting Nutritional Goals for Low-Birth-Weight Infants, Sauls HS, Bachhuber WL, Lewis LA (Eds), Ross Laboratories, Columbus 1982. p.4.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziegler EE, O'Donnell AM, Nelson SE, Fomon SJ. Body composition of the reference fetus. Growth 1976; 40:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellis KJ, Shypailo RJ, Schanler RJ, Langston C. Body elemental composition of the neonate: New reference data. Am J Hum Biol 1993; 5:323.
          </a>
         </li>
         <li class="breakAll">
          Sinclair JC. Energy balance of the newborn. In: Temperature Regulation and Energy Metabolism in the Newborn, Sinclair JC (Ed), Grune &amp; Stratton, New York 1978. p.187.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agostoni C, Buonocore G, Carnielli VP, et al. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010; 50:85.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics Committee on Nutrition. Nutritional needs of the preterm infant. In: Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2019. p.113.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstein MR, Oh W. Oxygen consumption in infants with bronchopulmonary dysplasia. J Pediatr 1981; 99:958.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yunis KA, Oh W. Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia. J Pediatr 1989; 115:127.
          </a>
         </li>
         <li class="breakAll">
          Ziegler EE, Biga RL, Fomon SJ. Nutritional requirements of the premature infant. In: Textbook of Pediatric Nutrition, Suskind RM (Ed), Raven Press, New York 1981. p.29.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ehrenkranz RA, Younes N, Lemons JA, et al. Longitudinal growth of hospitalized very low birth weight infants. Pediatrics 1999; 104:280.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shaffer SG, Quimiro CL, Anderson JV, Hall RT. Postnatal weight changes in low birth weight infants. Pediatrics 1987; 79:702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gross SJ, Eckerman CO. Normative early head growth in very-low-birth-weight infants. J Pediatr 1983; 103:946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Usher R, McLean F. Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. J Pediatr 1969; 74:901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fenton TR, Anderson D, Groh-Wargo S, et al. An Attempt to Standardize the Calculation of Growth Velocity of Preterm Infants-Evaluation of Practical Bedside Methods. J Pediatr 2018; 196:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Polberger SK, Axelsson IE, Räihä NC. Urinary and serum urea as indicators of protein metabolism in very low birthweight infants fed varying human milk protein intakes. Acta Paediatr Scand 1990; 79:737.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maffei D, Brewer M, Codipilly C, et al. Early oral colostrum administration in preterm infants. J Perinatol 2020; 40:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sohn K, Kalanetra KM, Mills DA, Underwood MA. Buccal administration of human colostrum: impact on the oral microbiota of premature infants. J Perinatol 2016; 36:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee J, Kim HS, Jung YH, et al. Oropharyngeal colostrum administration in extremely premature infants: an RCT. Pediatrics 2015; 135:e357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodriguez NA, Meier PP, Groer MW, Zeller JM. Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives. J Perinatol 2009; 29:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trang S, Zupancic JAF, Unger S, et al. Cost-Effectiveness of Supplemental Donor Milk Versus Formula for Very Low Birth Weight Infants. Pediatrics 2018; 141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           COMMITTEE ON NUTRITION, SECTION ON BREASTFEEDING, COMMITTEE ON FETUS AND NEWBORN. Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States. Pediatrics 2017; 139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ESPGHAN Committee on Nutrition, Arslanoglu S, Corpeleijn W, et al. Donor human milk for preterm infants: current evidence and research directions. J Pediatr Gastroenterol Nutr 2013; 57:535.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker MG, Burnham LA, Kerr S, et al. Prevalence and predictors of donor milk programs among U.S. advanced neonatal care facilities. J Perinatol 2020; 40:672.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quigley M, Embleton ND, McGuire W. Formula versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev 2019; 7:CD002971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Subudhi S, Sriraman N. Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States. Pediatrics 2021; 147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sisk PM, Lovelady CA, Gruber KJ, et al. Human milk consumption and full enteral feeding among infants who weigh &lt;/= 1250 grams. Pediatrics 2008; 121:e1528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koenig WJ, Amarnath RP, Hench V, Berseth CL. Manometrics for preterm and term infants: a new tool for old questions. Pediatrics 1995; 95:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berseth CL, Nordyke CK, Valdes MG, et al. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res 1992; 31:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schanler RJ, Shulman RJ, Lau C, et al. Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method. Pediatrics 1999; 103:434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah SD, Dereddy N, Jones TL, et al. Early versus Delayed Human Milk Fortification in Very Low Birth Weight Infants-A Randomized Controlled Trial. J Pediatr 2016; 174:126.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young L, Oddie SJ, McGuire W. Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2022; 1:CD001970.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitale R, Ferguson K, Talej M, et al. Early Enteral Feeding for Preterm or Low Birth Weight Infants: a Systematic Review and Meta-analysis. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berseth CL. Effect of early feeding on maturation of the preterm infant's small intestine. J Pediatr 1992; 120:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meetze WH, Valentine C, McGuigan JE, et al. Gastrointestinal priming prior to full enteral nutrition in very low birth weight infants. J Pediatr Gastroenterol Nutr 1992; 15:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dunn L, Hulman S, Weiner J, Kliegman R. Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: preliminary report of a randomized trial. J Pediatr 1988; 112:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Slagle TA, Gross SJ. Effect of early low-volume enteral substrate on subsequent feeding tolerance in very low birth weight infants. J Pediatr 1988; 113:526.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shulman RJ, Schanler RJ, Lau C, et al. Early feeding, feeding tolerance, and lactase activity in preterm infants. J Pediatr 1998; 133:645.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shulman RJ, Schanler RJ, Lau C, et al. Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants. Pediatr Res 1998; 44:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berseth CL, Nordyke C. Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants. Am J Physiol 1993; 264:G1046.
          </a>
         </li>
         <li class="breakAll">
          Schanler RJ. The low birth weight infant. In: Nutrition in Pediatrics, Walker WA, Watkins JB, Duggan C (Eds), BC Decker, Hamilton, Ontario 2003. p.491.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Bloom SR, Aynsley-Green A. Gut hormones and 'minimal enteral feeding'. Acta Paediatr Scand 1986; 75:719.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rayyis SF, Ambalavanan N, Wright L, Carlo WA. Randomized trial of "slow" versus "fast" feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants. J Pediatr 1999; 134:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krishnamurthy S, Gupta P, Debnath S, Gomber S. Slow versus rapid enteral feeding advancement in preterm newborn infants 1000-1499 g: a randomized controlled trial. Acta Paediatr 2010; 99:42.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Karagol BS, Zenciroglu A, Okumus N, Polin RA. Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g. JPEN J Parenter Enteral Nutr 2013; 37:223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maas C, Franz AR, von Krogh S, et al. Growth and morbidity of extremely preterm infants after early full enteral nutrition. Arch Dis Child Fetal Neonatal Ed 2018; 103:F79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salas AA, Li P, Parks K, et al. Early progressive feeding in extremely preterm infants: a randomized trial. Am J Clin Nutr 2018; 107:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dorling J, Abbott J, Berrington J, et al. Controlled Trial of Two Incremental Milk-Feeding Rates in Preterm Infants. N Engl J Med 2019; 381:1434.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oddie SJ, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2021; 8:CD001241.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang WC, Fogel A, Lauria ME, et al. Fast Feed Advancement for Preterm and Low Birth Weight Infants: A Systematic Review and Meta-analysis. Pediatrics 2022; 150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKeown RE, Marsh TD, Amarnath U, et al. Role of delayed feeding and of feeding increments in necrotizing enterocolitis. J Pediatr 1992; 121:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeMauro SB, Abbasi S, Lorch S. The impact of feeding interval on feeding outcomes in very low birth-weight infants. J Perinatol 2011; 31:481.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Assad M, Sherman J, et al. Safety of Cow's Milk-Derived Fortifiers Used with an All-Human Milk Base Diet in Very Low Birthweight Preterm Infants. Neonatal Today 2020; 15:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Assad M, Sherman J, et al. Safety of Cow's Milk-Derived Fortifiers used with an All Human Milk Base Diet in Very Low Birthweight Preterm Infants: Part II. Neonatal Today 2020; 15:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Boscardin J, Abrams SA. Preterm Infants Fed Cow's Milk-Derived Fortifier Had Adverse Outcomes Despite a Base Diet of Only Mother's Own Milk. Breastfeed Med 2020; 15:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salas AA, Gunawan E, Nguyen K, et al. Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial. Pediatrics 2023; 152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thanigainathan S, Abiramalatha T. Early fortification of human milk versus late fortification to promote growth in preterm infants. Cochrane Database Syst Rev 2020; 7:CD013392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sullivan S, Schanler RJ, Kim JH, et al. An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products. J Pediatr 2010; 156:562.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hilditch C, Keir A, Collins CT, et al. Early versus delayed introduction of human milk fortification in enterally fed preterm infants: A systematic review and meta-analysis. J Paediatr Child Health 2022; 58:30.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travers CP, Wang T, Salas AA, et al. Higher- or Usual-Volume Feedings in Infants Born Very Preterm: A Randomized Clinical Trial. J Pediatr 2020; 224:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abiramalatha T, Thomas N, Thanigainathan S. High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants. Cochrane Database Syst Rev 2021; 3:CD012413.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jadcherla SR, Wang M, Vijayapal AS, Leuthner SR. Impact of prematurity and co-morbidities on feeding milestones in neonates: a retrospective study. J Perinatol 2010; 30:201.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jadcherla SR, Kliegman RM. Studies of feeding intolerance in very low birth weight infants: definition and significance. Pediatrics 2002; 109:516.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mihatsch WA, von Schoenaich P, Fahnenstich H, et al. The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants. Pediatrics 2002; 109:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh B, Rochow N, Chessell L, et al. Gastric Residual Volume in Feeding Advancement in Preterm Infants (GRIP Study): A Randomized Trial. J Pediatr 2018; 200:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Riskin A, Cohen K, Kugelman A, et al. The Impact of Routine Evaluation of Gastric Residual Volumes on the Time to Achieve Full Enteral Feeding in Preterm Infants. J Pediatr 2017; 189:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abiramalatha T, Thanigainathan S, Ninan B. Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants. Cochrane Database Syst Rev 2019; 7:CD012937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker LA, Weaver M, Murgas Torrazza RJ, et al. Effect of Gastric Residual Evaluation on Enteral Intake in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatr 2019; 173:534.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar J, Meena J, Mittal P, et al. Routine prefeed gastric aspiration in preterm infants: a systematic review and meta-analysis. Eur J Pediatr 2021; 180:2367.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mihatsch WA, Franz AR, Lindner W, Pohlandt F. Meconium passage in extremely low birthweight infants and its relation to very early enteral nutrition. Acta Paediatr 2001; 90:409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abramo TJ, Evans JS, Kokomoor FW, Kantak AD. Occult blood in stools and necrotizing enterocolitis. Is there a relationship? Am J Dis Child 1988; 142:451.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guillet R, Stoll BJ, Cotten CM, et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117:e137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patil UP, Bailey SM, Wachtel EV, et al. Efficacy of and potential morbidities associated with the use of antacid medications in preterm neonates. J Perinat Med 2017; 45:947.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patole S, Rao S, Doherty D. Erythromycin as a prokinetic agent in preterm neonates: a systematic review. Arch Dis Child Fetal Neonatal Ed 2005; 90:F301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nuntnarumit P, Kiatchoosakun P, Tantiprapa W, Boonkasidecha S. Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants. J Pediatr 2006; 148:600.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ng E, Shah VS. Erythromycin for the prevention and treatment of feeding intolerance in preterm infants. Cochrane Database Syst Rev 2008; :CD001815.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Basu S, Smith S. Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis. Eur J Pediatr 2021; 180:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eberly MD, Eide MB, Thompson JL, Nylund CM. Azithromycin in early infancy and pyloric stenosis. Pediatrics 2015; 135:483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aynsley-Green A, Adrian TE, Bloom SR. Feeding and the development of enteroinsular hormone secretion in the preterm infant: effects of continuous gastric infusions of human milk compared with intermittent boluses. Acta Paediatr Scand 1982; 71:379.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rogers SP, Hicks PD, Hamzo M, et al. Continuous feedings of fortified human milk lead to nutrient losses of fat, calcium and phosphorous. Nutrients 2010; 2:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadrudin Premji S, Chessell L, Stewart F. Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams. Cochrane Database Syst Rev 2021; 6:CD001819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parker P, Stroop S, Greene H. A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease. J Pediatr 1981; 99:360.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Ville K, Knapp E, Al-Tawil Y, Berseth CL. Slow infusion feedings enhance duodenal motor responses and gastric emptying in preterm infants. Am J Clin Nutr 1998; 68:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watson J, McGuire W. Transpyloric versus gastric tube feeding for preterm infants. Cochrane Database Syst Rev 2013; :CD003487.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tume LN, Valla FV, Joosten K, et al. Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations. Intensive Care Med 2020; 46:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davey AM, Wagner CL, Cox C, Kendig JW. Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial. J Pediatr 1994; 124:795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clyman R, Wickremasinghe A, Jhaveri N, et al. Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus. J Pediatr 2013; 163:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maheshwari A, Patel RM, Christensen RD. Anemia, red blood cell transfusions, and necrotizing enterocolitis. Semin Pediatr Surg 2018; 27:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jasani B, Rao S, Patole S. Withholding Feeds and Transfusion-Associated Necrotizing Enterocolitis in Preterm Infants: A Systematic Review. Adv Nutr 2017; 8:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patel RM, Knezevic A, Shenvi N, et al. Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016; 315:889.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lucas A, Fewtrell MS, Morley R, et al. Randomized trial of nutrient-enriched formula versus standard formula for postdischarge preterm infants. Pediatrics 2001; 108:703.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bishop NJ, King FJ, Lucas A. Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital. Arch Dis Child 1993; 68:573.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5014 Version 66.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10585989" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Workshop summary: nutrition of the extremely low birth weight infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4032137" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Fortified mothers' milk for very low birth weight infants: results of growth and nutrient balance studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6694010" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Human milk intake and growth in exclusively breast-fed infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14510321" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Growth failure in the preterm infant: can we catch up?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34635582" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921640" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Policy Statement: Breastfeeding and the Use of Human Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921640" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Policy Statement: Breastfeeding and the Use of Human Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1010389" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Body composition of the reference fetus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28548418" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Body elemental composition of the neonate: New reference data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28548418" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Body elemental composition of the neonate: New reference data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19881390" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19881390" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6895525" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Oxygen consumption in infants with bronchopulmonary dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2500510" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2500510" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Effects of intravenous glucose loading on oxygen consumption, carbon dioxide production, and resting energy expenditure in infants with bronchopulmonary dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10429008" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Longitudinal growth of hospitalized very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3575025" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Postnatal weight changes in low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6644433" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Normative early head growth in very-low-birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5781799" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Intrauterine growth of live-born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29246464" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : An Attempt to Standardize the Calculation of Growth Velocity of Preterm Infants-Evaluation of Practical Bedside Methods.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2239266" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Urinary and serum urea as indicators of protein metabolism in very low birthweight infants fed varying human milk protein intakes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31748654" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Early oral colostrum administration in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26658119" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Buccal administration of human colostrum: impact on the oral microbiota of premature infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25624376" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Oropharyngeal colostrum administration in extremely premature infants: an RCT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18769379" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Oropharyngeal administration of colostrum to extremely low birth weight infants: theoretical perspectives.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29490909" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Cost-Effectiveness of Supplemental Donor Milk Versus Formula for Very Low Birth Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27994111" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Donor Human Milk for the High-Risk Infant: Preparation, Safety, and Usage Options in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24084373" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Donor human milk for preterm infants: current evidence and research directions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32103161" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Prevalence and predictors of donor milk programs among U.S. advanced neonatal care facilities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31322731" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Formula versus donor breast milk for feeding preterm or low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33483451" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Islamic Beliefs About Milk Kinship and Donor Human Milk in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18519456" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Human milk consumption and full enteral feeding among infants who weigh&lt;/= 1250 grams.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7838635" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Manometrics for preterm and term infants: a new tool for old questions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1635821" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9925837" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Feeding strategies for premature infants: randomized trial of gastrointestinal priming and tube-feeding method.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27112041" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Early versus Delayed Human Milk Fortification in Very Low Birth Weight Infants-A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35049036" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Delayed introduction of progressive enteral feeds to prevent necrotising enterocolitis in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921673" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Early Enteral Feeding for Preterm or Low Birth Weight Infants: a Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1593357" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of early feeding on maturation of the preterm infant's small intestine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1403464" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Gastrointestinal priming prior to full enteral nutrition in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2895173" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: preliminary report of a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3137320" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Effect of early low-volume enteral substrate on subsequent feeding tolerance in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9821422" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Early feeding, feeding tolerance, and lactase activity in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9773840" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Early feeding, antenatal glucocorticoids, and human milk decrease intestinal permeability in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8333531" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8333531" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Enteral nutrients promote postnatal maturation of intestinal motor activity in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3105234" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Gut hormones and 'minimal enteral feeding'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10064664" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Randomized trial of "slow" versus "fast" feed advancements on the incidence of necrotizing enterocolitis in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20002013" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Slow versus rapid enteral feeding advancement in preterm newborn infants 1000-1499 g: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22664861" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Randomized controlled trial of slow vs rapid enteral feeding advancements on the clinical outcomes of preterm infants with birth weight 750-1250 g.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28733478" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Growth and morbidity of extremely preterm infants after early full enteral nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29529231" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Early progressive feeding in extremely preterm infants: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31597020" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Controlled Trial of Two Incremental Milk-Feeding Rates in Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34427330" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921676" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Fast Feed Advancement for Preterm and Low Birth Weight Infants: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1432431" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Role of delayed feeding and of feeding increments in necrotizing enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21252961" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : The impact of feeding interval on feeding outcomes in very low birth-weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Safety of Cow's Milk-Derived Fortifiers Used with an All-Human Milk Base Diet in Very Low Birthweight Preterm Infants
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Safety of Cow's Milk-Derived Fortifiers used with an All Human Milk Base Diet in Very Low Birthweight Preterm Infants: Part II
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32239968" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Preterm Infants Fed Cow's Milk-Derived Fortifier Had Adverse Outcomes Despite a Base Diet of Only Mother's Own Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37551512" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Early Human Milk Fortification in Infants Born Extremely Preterm: A Randomized Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32726863" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Early fortification of human milk versus late fortification to promote growth in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20036378" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34669996" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Early versus delayed introduction of human milk fortification in enterally fed preterm infants: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32464224" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Higher- or Usual-Volume Feedings in Infants Born Very Preterm: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33733486" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : High versus standard volume enteral feeds to promote growth in preterm or low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19812589" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Impact of prematurity and co-morbidities on feeding milestones in neonates: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11875150" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Studies of feeding intolerance in very low birth weight infants: definition and significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11875141" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : The significance of gastric residuals in the early enteral feeding advancement of extremely low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29866595" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Gastric Residual Volume in Feeding Advancement in Preterm Infants (GRIP Study): A Randomized Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28625498" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : The Impact of Routine Evaluation of Gastric Residual Volumes on the Time to Achieve Full Enteral Feeding in Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31425604" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Routine monitoring of gastric residual for prevention of necrotising enterocolitis in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31034045" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Effect of Gastric Residual Evaluation on Enteral Intake in Extremely Preterm Infants: A Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34018044" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Routine prefeed gastric aspiration in preterm infants: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11332932" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Meconium passage in extremely low birthweight infants and its relation to very early enteral nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3126646" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Occult blood in stools and necrotizing enterocolitis. Is there a relationship?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16390920" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28141547" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Efficacy of and potential morbidities associated with the use of antacid medications in preterm neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15899929" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Erythromycin as a prokinetic agent in preterm neonates: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16737869" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Efficacy of oral erythromycin for treatment of feeding intolerance in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18646077" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Erythromycin for the prevention and treatment of feeding intolerance in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33044576" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Macrolides for the prevention and treatment of feeding intolerance in preterm low birth weight infants: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25687145" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Azithromycin in early infancy and pyloric stenosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6814175" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Feeding and the development of enteroinsular hormone secretion in the preterm infant: effects of continuous gastric infusions of human milk compared with intermittent boluses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22254018" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Continuous feedings of fortified human milk lead to nutrient losses of fat, calcium and phosphorous.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34165778" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Continuous nasogastric milk feeding versus intermittent bolus milk feeding for preterm infants less than 1500 grams.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6790688" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : A controlled comparison of continuous versus intermittent feeding in the treatment of infants with intestinal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9665103" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Slow infusion feedings enhance duodenal motor responses and gastric emptying in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23450542" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Transpyloric versus gastric tube feeding for preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32077997" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Nutritional support for children during critical illness: European Society of Pediatric and Neonatal Intensive Care (ESPNIC) metabolism, endocrine and nutrition section position statement and clinical recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8176571" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Feeding premature infants while low umbilical artery catheters are in place: a prospective, randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23472765" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Enteral feeding during indomethacin and ibuprofen treatment of a patent ductus arteriosus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29275817" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Anemia, red blood cell transfusions, and necrotizing enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28916576" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Withholding Feeds and Transfusion-Associated Necrotizing Enterocolitis in Preterm Infants: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26934258" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11533340" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Randomized trial of nutrient-enriched formula versus standard formula for postdischarge preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8323358" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
